| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.059 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.056 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |